Integration of phospholipid-hyaluronic acid-methotrexate nanocarrier assembly and amphiphilic drug–drug conjugate for synergistic targeted delivery and combinational tumor therapy-Reference-Cited by-同舟云学术

Integration of phospholipid-hyaluronic acid-methotrexate nanocarrier assembly and amphiphilic drug–drug conjugate for synergistic targeted delivery and combinational tumor therapy

Published:2018 Issue:7 Volume:6 Page:1818-1833
ISSN:2047-4830
Container-title:Biomaterials Science
language:en
Short-container-title:Biomater. Sci.

Author:

Li Yang¹²³⁴⁵^ORCID,Zhang Huabing¹²³⁴⁵,Chen Yilin⁶⁷⁴⁵⁸,Ma Jinyuan⁶⁷⁴⁵⁸,Lin Jinyan¹²³⁴⁵,Zhang Yinying¹²³⁴⁵,Fan Zhongxiong¹²³⁴⁵,Su Guanghao⁹¹⁰⁸,Xie Liya¹¹¹²⁸,Zhu Xuan⁶⁷⁴⁵⁸,Hou Zhenqing¹²³⁴⁵^ORCID

Affiliation:

1. Key Laboratory of Biomedical Engineering of Fujian Province & Research Center of Biomedical Engineering of Xiamen

2. Department of Biomaterials

3. College of Materials

4. Xiamen University

5. Xiamen 361005

6. School of Pharmaceutical Science

7. Fujian Provincial Key Laboratory of Innovative Drug Target Research

8. China

9. Children's Hospital of Soochow University

10. Suzhou 215025

11. The First Affiliated Hospital of Xiamen University

12. Xiamen 361002

Abstract

A novel synergistic-targeting polymeric delivery system was developed to carry drug–drug conjugate for boosting dual-drug co-delivery and combinational tumor therapy.

Funder

National Natural Science Foundation of China

China Postdoctoral Science Foundation

Natural Science Foundation of Fujian Province

Xiamen Municipal Bureau of Science and Technology

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering

Link

http://pubs.rsc.org/en/content/articlepdf/2018/BM/C8BM00009C

Reference57 articles.